As expected, PD-L1 and IDO1 expression were elevated in DDIR-positive tumours, given that these genes are constituent parts of the signature; however, upregulation of non-signature checkpoint genes was also seen in the transcriptomic data. The gene discussed is IDO1; the disease is neoplasm.